전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
annoshakututkimuksessa saadut suojaavat vasta- ainetasot, serokonversiofrekvenssit ja serokonversiokertoimet lievästi muuntuneita h5n1 variantteja vastaan on esitetty alla olevassa taulukossa.
in the dose finding studythe seroprotection rate, seroconversion rate and seroconversion factor against h5n1 drift variants 21 days after the second dose were as follows:
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
aikuisilla ja vanhemmilla ihmisillä raportoidut serosuojaluvut, serokonversioluvut ja serokonversiokertoimet olivat celvapan (h1n1)v -rokotteeseen verrattavia.
the seroprotection rates, seroconversion rates and seroconversion factors reported in adults and older subjects were comparable with celvapan (h1n1)v.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
koehenkilöillä, jotka saivat 7, 5 μg adjuvanttia sisältämätöntä rokotetta (n = 42), mitattiin mn- testillä seuraavat ristineutraloivien vasta- aineiden seroneutralointiluvut (koehenkilöillä, joiden neutraloivien vasta- aineiden titteri oli > 20), serokonversioluvut ja serokonversiokertoimet:
in a dose-finding study in adults aged 18 – 45 years investigating various dose levels of adjuvanted and non-adjuvanted formulations of the a/ vietnam/ 1203/ 2004 strain vaccine the rates of subjects with 6 neutralising antibody titres > 20, seroconversion rates and seroconversion factor for cross-neutralising antibodies as measured by mn in subjects who received the 7.5 µg non-adjuvanted formulation (n=42) were as follows:
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 보이지 않는 HTML 형식이 포함되어 있습니다
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.